Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06028035 · ClinicalTrials.gov registry record · NA
A Study of Hemp Hull WFI for IBS Diarrhea
A NA study of Irritable Bowel Syndrome-bile Acid Diarrhea, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06028035 is a NA study of Irritable Bowel Syndrome-bile Acid Diarrhea that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06028035, a NA study of Irritable Bowel Syndrome-bile Acid Diarrhea, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is the effect of a study bar, which contains 15 grams of insoluble dietary fiber total sourced from Hemp hulls, on intestinal permeability in irritable bowel syndrome (IBS)-bile acid diarrhea individuals.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT BB01
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-10-06 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06028035
The ClinicalTrials.gov registry entry for NCT06028035 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Irritable Bowel Syndrome-bile Acid Diarrhea appearing as the primary indexed condition, and to 1 intervention - of which BB01 is the first listed.
NCT06028035 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06028035 about?
NCT06028035 is a clinical study titled "A Study of Hemp Hull WFI for IBS Diarrhea". The purpose of this study is the effect of a study bar, which contains 15 grams of insoluble dietary fiber total sourced from Hemp hulls, on intestinal permeability in irritable bowel syndrome (IBS)-bile acid diarrhea individuals.
What is the current status of trial NCT06028035?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-10-06. Estimated completion is 2024-05-01.
What conditions does trial NCT06028035 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome-bile Acid Diarrhea.
What interventions are being tested in trial NCT06028035?
The interventions under investigation include: BB01 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06028035?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06028035 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.